Login


TI Ref No : 531841766
Description : The Dak-gesundheit Intends To Conclude A Non-exclusive Discount Agreement Under ยง 130a Abs. 8 Sgb V For The Active Ingredient Mesalazine (excluding Dafo Rsu + Kli), Atc A07ec02 For The Period From 01.06.2026 To 31.05.2028, With An Option To Extend For 1x1
Date : 2026-04-21
Deadline : 2029-04-05
Document Type : Tenders
View Details
Whats app